Proceedings of the National Academy of Sciences · 2017 · 56 citations · 88 references
Life SciencesImmunologyMolecular GeneticsImmunogeneticsInnate ImmunityMolecular ImmunologyInnate Immune ActivationInnate Immune ReceptorsInnate Immune RecognitionInnate Immune ResponseInnate Immune Signaling PathwaysToll-like ReceptorsMecp2-related DisordersMyd88-dependent SignalingToll-like Receptor 1 GeneticsToll-like Receptor SignalingToll-like Receptor Signaling CascadesToll-like Receptor Signaling Pathway GeneticsToll-like Receptor Signaling PathwaysToll-like Receptor-mediated Innate Immune Response
Significance We report the discovery of complete human interleukin-1 receptor (IL-1R)-associated kinase 1 (IRAK-1) deficiency resulting from a de novo Xq28 microdeletion encompassing MECP2 and IRAK1 in a boy. Like many boys with MECP2 defects, this patient died very early. IRAK-1 is a component of the Toll-like receptor (TLR)/IL-1R (TIR) signaling pathway. Unlike patients with autosomal-recessive complete deficiency of MyD88 or IRAK-4, two other components of the TIR pathway, this patient presented no invasive bacterial infections. We analyzed the impact of human IRAK-1 deficiency in fibroblasts and leukocytes. The role of IRAK-1 in signaling downstream from IL-1R and TLRs differed according to cell type. These findings reveal similarities and differences in the role of IRAK-1 in the TLR and IL-1R pathways between mice and humans.
88
MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Maria H. Chahrour, Sung Yun Jung, Chad A. Shaw et al. · Science · 2008 · 1.8K citations
TRAF6 is a signal transducer for interleukin-1
Zhaodan Cao, Jessie Xiong, Masahiro Takeuchi et al. · Nature · 1996 · 1.3K citations